REACTION OF HUMAN GRANULOPOIESIS TO HIGH-DOSE CYCLOPHOSPHAMIDE THERAPY

被引:31
作者
LOHRMANN, HP [1 ]
SCHREML, W [1 ]
FLIEDNER, TM [1 ]
HEIMPEL, H [1 ]
机构
[1] UNIV ULM,ZENTRUM KLIN GRUNDLAGENFORSCH,KLIN PHYSIOL ABT,D-7900 ULM,FED REP GER
来源
BLUT | 1979年 / 38卷 / 01期
关键词
Bone marrow; Cyclophosphamide; Granulopoiesis; Hemopoietic stem cells;
D O I
10.1007/BF01082923
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The reaction pattern of an unperturbed human granulopoiesis to pulses of high-dose chemotherapy (cyclophosphamide 2000 mg/m2 plus vincristine 1.4 mg/m2 or adriamycin 20 mg/m2) was serially studied in 6 patients. The stem cells committed to granulopoiesis (CFU-C) of the bone marrow and the cells of the proliferative granulocytic marrow pool were considerably reduced during the first 8 days. Granulopoietic regeneration was first recognizable by increased proliferative activity of bone marrow CFU-C (3H-thymi. dine technique). The cytotoxic drug-induced injury to the early compartments of granulopoiesis, and granulocytic regeneration proceed sequentially through the ensuing, increasingly differentiated granulocytic compartments. In the peripheral blood, depletion and repletion of the CFU-C pool precede the corresponding changes of segmented neutrophils by 7 to 9 days; during granulocytic regeneration, peripheral blood CFU-C show a transient greatly overshooting decrease. © 1979 Springer-Verlag.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 21 条
[1]  
BERGSAGEL DE, 1968, CAN MED ASSOC J, V98, P532
[2]  
BURGESS AW, 1977, BLOOD, V49, P573
[3]   IN-VITRO GROWTH OF GRANULOCYTIC AND MONONUCLEAR CELL COLONIES FROM BLOOD OF NORMAL INDIVIDUALS [J].
CHERVENICK, PA ;
BOGGS, DR .
BLOOD-THE JOURNAL OF HEMATOLOGY, 1971, 37 (02) :131-+
[4]  
CHERVENICK PA, 1973, J CLIN INVEST, V52, pA18
[5]  
Cronkite E.P., 1969, SERIES HAEMATOLOGICA, V2, P3
[6]  
EAGAN RT, 1974, CANCER-AM CANCER SOC, V33, P527, DOI 10.1002/1097-0142(197402)33:2<527::AID-CNCR2820330230>3.0.CO
[7]  
2-R
[8]  
Gordon MY, 1977, EXPT HEMATOLOGY TODA
[9]  
HENDERSON ES, 1974, DRUGS HEMATOLOGIC RE, P207
[10]  
ISCOVE NN, 1970, P SOC EXP BIOL MED, V134, P33